NovaSterilis

NovaSterilis is the global leader in the development and manufacturing of supercritical carbon dioxide (scCO2) processes for biomaterials and medical devices, including the decellularization and sterilization of allograft and xenograft tissues. NovaSterilis scCO2 technologies exceed the highest standards for product safety and performance. These processes have been used to treat ortho/dental/spinal products used in over 300,000 surgeries over the past 8 years. scCO2 involves lower temperatures (31C) and pressure above 1100 psi. This lower temperature makes scCO2 ideal for materials that are temperature sensitive or reactive with other forms of sterilization. scCO2 can penetrate and sterilize delicate products and materials,...

Decellularization,terminal sterilization,supercritical carbon dioxide,allografts,xenografts,donor tissue,ecm,pericardium,r&d equipment,cro,biomaterials,pressure vessel,process validation,microbiology testing,material compatability,cannabis sterilization,endoscope sterilization,tissue banking,supercritical fluids,and carbon dioxide

Novasterilis operates in the Medical equipment manufacturing industry.

Novasterilis's revenue is 11m - 100m

Novasterilis has 11 - 50 employees.